These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 15012919)

  • 21. Predictors of elevated B-type natriuretic peptide concentrations in dyspneic patients without heart failure: an analysis from the breathing not properly multinational study.
    Knudsen CW; Clopton P; Westheim A; Klemsdal TO; Wu AH; Duc P; McCord J; Nowak RM; Hollander JE; Storrow AB; Abraham WT; McCullough PA; Maisel AS; Omland T
    Ann Emerg Med; 2005 Jun; 45(6):573-80. PubMed ID: 15940086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.
    Anwaruddin S; Lloyd-Jones DM; Baggish A; Chen A; Krauser D; Tung R; Chae C; Januzzi JL
    J Am Coll Cardiol; 2006 Jan; 47(1):91-7. PubMed ID: 16386670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic performance and cost effectiveness of measurements of plasma N-terminal pro brain natriuretic peptide in patients presenting with acute dyspnea or peripheral edema.
    Behnes M; Brueckmann M; Ahmad-Nejad P; Lang S; Wolpert C; Elmas E; Kaelsch T; Gruettner J; Weiss C; Borggrefe M; Neumaier M
    Int J Cardiol; 2009 Jun; 135(2):165-74. PubMed ID: 18603317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic and prognostic value of uric acid in patients with acute dyspnea.
    Reichlin T; Potocki M; Breidthardt T; Noveanu M; Hartwiger S; Burri E; Klima T; Stelzig C; Laule K; Mebazaa A; Christ M; Mueller C
    Am J Med; 2009 Nov; 122(11):1054.e7-1054.e14. PubMed ID: 19854335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gender-specific risk stratification with B-type natriuretic peptide levels in patients with acute dyspnea: insights from the B-type natriuretic peptide for acute shortness of breath evaluation study.
    Christ M; Laule-Kilian K; Hochholzer W; Klima T; Breidthardt T; Perruchoud AP; Mueller C
    J Am Coll Cardiol; 2006 Nov; 48(9):1808-12. PubMed ID: 17084254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Brain-natriuretic-peptide (BNP) for improvement of the diagnostic determination in a conserving emergency room].
    Post F; Peetz D; Knoess P; Rupprecht HJ
    Z Kardiol; 2004; 93 Suppl 4():IV31-5. PubMed ID: 15085364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. B-type natriuretic peptide testing and the accuracy of heart failure diagnosis in the emergency department.
    Lokuge A; Lam L; Cameron P; Krum H; de Villiers S; Bystrzycki A; Naughton MT; Eccleston D; Flannery G; Federman J; Schneider HG
    Circ Heart Fail; 2010 Jan; 3(1):104-10. PubMed ID: 19933409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath.
    Maisel A; Hollander JE; Guss D; McCullough P; Nowak R; Green G; Saltzberg M; Ellison SR; Bhalla MA; Bhalla V; Clopton P; Jesse R;
    J Am Coll Cardiol; 2004 Sep; 44(6):1328-33. PubMed ID: 15364340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in assessment of acute dyspnea.
    Alibay Y; Beauchet A; El Mahmoud R; Schmitt C; Brun-Ney D; Benoit MO; Dubourg O; Boileau C; Jondeau G; Puy H
    Biomed Pharmacother; 2005; 59(1-2):20-4. PubMed ID: 15740931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study.
    Januzzi JL; Camargo CA; Anwaruddin S; Baggish AL; Chen AA; Krauser DG; Tung R; Cameron R; Nagurney JT; Chae CU; Lloyd-Jones DM; Brown DF; Foran-Melanson S; Sluss PM; Lee-Lewandrowski E; Lewandrowski KB
    Am J Cardiol; 2005 Apr; 95(8):948-54. PubMed ID: 15820160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Usefulness of B-type natriuretic peptide (BNP) for the diagnosis of new-onset heart failure with a preserved left ventricular systolic function in longstanding hypertensive patients with acute dyspnea].
    Arquès S; Roux E; Sbragia P; Pieri B; Gélisse R; Luccioni R; Ambrosi P
    Arch Mal Coeur Vaiss; 2007 Feb; 100(2):113-20. PubMed ID: 17474496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of the plasma brain natriuretic peptide in differentiating patients with congestive heart failure from other diseases.
    Sirithunyanont C; Leowattana W; Sukumalchantra Y; Chaisupamonkollarp S; Watanawaroon S; Chivatanaporn B; Bhuripanyo K; Mahanonda N
    J Med Assoc Thai; 2003 May; 86 Suppl 1():S87-95. PubMed ID: 12866774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acoustic cardiography S3 detection use in problematic subgroups and B-type natriuretic peptide "gray zone": secondary results from the Heart failure and Audicor technology for Rapid Diagnosis and Initial Treatment Multinational Investigation.
    Maisel AS; Peacock WF; Shah KS; Clopton P; Diercks D; Hiestand B; Kontos MC; Mueller C; Nowak R; Chen WJ; Collins SP
    Am J Emerg Med; 2011 Oct; 29(8):924-31. PubMed ID: 20627217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic and prognostic usefulness of natriuretic peptides in emergency department patients with dyspnea.
    Collins SP; Ronan-Bentle S; Storrow AB
    Ann Emerg Med; 2003 Apr; 41(4):532-45. PubMed ID: 12658254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Levels of serum brain natriuretic peptide in children with congestive heart failure or with severe pneumonia].
    An JD; Zhang YP; Zhou JH
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Jun; 8(3):201-4. PubMed ID: 16787591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Non-radioimmunometric NT-ProBNP and BNP assays: impact of diluent, age, gender, BMI].
    Alibay Y; Schmitt C; Beauchet A; Dubourg O; Alexandre JA; Boileau C; Jondeau G; Puy H
    Ann Biol Clin (Paris); 2005; 63(1):43-9. PubMed ID: 15689311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinical value of rapid assay for plasma B-type natriuretic peptide in differentiating congestive heart failure from pulmonary causes of dyspnoea.
    Zhao SQ; Hu YM; Li Q; Liu XR; Wang M; Zhang WY; Wu T; Nie XL; Zhao N; Wang LR
    Int J Clin Pract; 2008 Feb; 62(2):214-20. PubMed ID: 18081799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of N-terminal prohormone brain natriuretic peptide assay for etiologic diagnosis of acute dyspnea in elderly patients.
    Berdagué P; Caffin PY; Barazer I; Vergnes C; Sedighian S; Letrillard S; Pilossof R; Goutorbe F; Piot C; Reny JL
    Am Heart J; 2006 Mar; 151(3):690-8. PubMed ID: 16504634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study.
    McCullough PA; Duc P; Omland T; McCord J; Nowak RM; Hollander JE; Herrmann HC; Steg PG; Westheim A; Knudsen CW; Storrow AB; Abraham WT; Lamba S; Wu AH; Perez A; Clopton P; Krishnaswamy P; Kazanegra R; Maisel AS;
    Am J Kidney Dis; 2003 Mar; 41(3):571-9. PubMed ID: 12612980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in congestive heart failure management in the intensive care unit: B-type natriuretic peptides in evaluation of acute heart failure.
    Omland T
    Crit Care Med; 2008 Jan; 36(1 Suppl):S17-27. PubMed ID: 18158473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.